Reduced Cardiovascular Risk Following Bariatric Surgeries is Related to a Partial Recovery from “Adiposopathy”

[1]  A. Shankar,et al.  Positive Relationship Between Plasma Leptin Level and Hypertension , 2010, Hypertension.

[2]  G. Steinberg,et al.  Adipose tissue as an endocrine organ , 2010, Molecular and Cellular Endocrinology.

[3]  C. Apovian,et al.  Adiposopathy and bariatric surgery: is ‘sick fat’ a surgical disease? , 2009, International journal of clinical practice.

[4]  P. Schauer,et al.  Triglyceride Levels and Not Adipokine Concentrations Are Closely Related to Severity of Nonalcoholic Fatty Liver Disease in an Obesity Surgery Cohort , 2009, Obesity.

[5]  F. Folli,et al.  In Morbid Obesity, Metabolic Abnormalities and Adhesion Molecules Correlate with Visceral Fat, Not with Subcutaneous Fat: Effect of Weight Loss Through Surgery , 2009, Obesity surgery.

[6]  H. Taegtmeyer,et al.  Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery. , 2009, The American journal of medicine.

[7]  M. Blüher,et al.  Adipose tissue dysfunction in obesity. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[8]  A. Darzi,et al.  Effects of Bariatric Surgery on Cardiovascular Function , 2008 .

[9]  M. Quon,et al.  Leptin and Cardiovascular Disease: Response to Therapeutic Interventions , 2008, Circulation.

[10]  M. Christ-Crain,et al.  Increase in high molecular weight adiponectin by bariatric surgery‐induced weight loss , 2008, Diabetes, obesity & metabolism.

[11]  S. Ikramuddin,et al.  Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study. , 2007, The Journal of surgical research.

[12]  J. Kirwan,et al.  Obese Reproductive‐Age Women Exhibit a Proatherogenic Inflammatory Response During Hyperglycemia , 2007, Obesity.

[13]  L. Angrisani,et al.  Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[14]  M. Quon,et al.  Adiponectin and cardiovascular disease: response to therapeutic interventions. , 2007, Journal of the American College of Cardiology.

[15]  C. Block,et al.  Mechanisms linking obesity with cardiovascular disease , 2006, Nature.

[16]  L. Blonde,et al.  Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? , 2006, Expert review of cardiovascular therapy.

[17]  R. Ahima.  Adipose Tissue as an Endocrine Organ , 2006, Obesity.

[18]  L. Angrisani,et al.  20: Laparoscopic Adjustable Gastric Banding versus Laparoscopic Roux-en-Y Gastric Bypass: 5 years results of a prospective randomized trial , 2006 .

[19]  Paul Poirier,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2006, Circulation.

[20]  A. Greenberg,et al.  Obesity and the role of adipose tissue in inflammation and metabolism. , 2006, The American journal of clinical nutrition.

[21]  N. Abate,et al.  Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. , 2005, Future cardiology.

[22]  P. Arner,et al.  Long-term prospective and controlled studies demonstrate adipose tissue hypercellularity and relative leptin deficiency in the postobese state. , 2005, The Journal of clinical endocrinology and metabolism.

[23]  W. Garvey,et al.  Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M400373-JLR200 , 2005, Journal of Lipid Research.

[24]  A. Rodríguez,et al.  Morbid Obesity, Hypertensive Disease and the Renin-Angiotensin-Aldosterone Axis , 2005, Obesity surgery.

[25]  G. Ballantyne,et al.  Changes in Insulin Resistance Following Bariatric Surgery and the Adipoinsular Axis: Role of the Adipocytokines, Leptin, Adiponectin and Resistin , 2005, Obesity surgery.

[26]  S. Kini,et al.  Nutritional Deficiencies following Bariatric Surgery: What Have We Learned? , 2005, Obesity surgery.

[27]  A. Scheen,et al.  [Bariatric surgery: 10-year results of the Swedish Obese Subjects Study]. , 2005, Revue medicale de Liege.

[28]  Steve N Caritis,et al.  Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization , 2004, The New England journal of medicine.

[29]  Henry Buchwald,et al.  Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.

[30]  C. Ballantyne,et al.  Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. , 2004, The Journal of clinical endocrinology and metabolism.

[31]  L. Kuller,et al.  The Chronic Inflammatory Hypothesis for the Morbidity Associated with Morbid Obesity: Implications and Effects of Weight Loss , 2004, Obesity surgery.

[32]  J. Miner.  The adipocyte as an endocrine cell. , 2004, Journal of animal science.

[33]  J. Clore,et al.  Diabetes and Hypertension in Severe Obesity and Effects of Gastric Bypass-Induced Weight Loss , 2003, Annals of surgery.

[34]  E. Minar,et al.  Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[35]  A. Zittermann.  Vitamin D in preventive medicine: are we ignoring the evidence? , 2003, The British journal of nutrition.

[36]  G. Frühbeck,et al.  Rationale for the existence of additional adipostatic hormones , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  K. Miller,et al.  Evaluation of Health Status and Quality of Life after Bariatric Surgery: Comparison of Standard Roux-en-Y Gastric Bypass, Vertical Banded Gastroplasty and Laparoscopic Adjustable Silicone Gastric Banding , 2000, Obesity surgery.

[38]  C. Buffington,et al.  Significant Changes in Blood Pressure, Glucose, and Lipids with Gastric Bypass Surgery , 1998, World Journal of Surgery.

[39]  T. Wadden,et al.  Tumor Necrosis Factor-α in Sera of Obese Patients: Fall with Weight Loss , 1998 .

[40]  R. Eckel,et al.  Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1997, Circulation.

[41]  HELEN B. HUBERT,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[42]  Manning Feinleib,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[43]  R. Kolotkin,et al.  Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. , 2009, The Journal of clinical endocrinology and metabolism.

[44]  Trudy Williams,et al.  Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery , 2007, Journal of Gastrointestinal Surgery.

[45]  M. Quon,et al.  Adiponectin and cardiovascular disease: response to therapeutic interventions. , 2007, Journal of the American College of Cardiology.

[46]  G. Frühbeck,et al.  The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. , 2007, Endocrinology.

[47]  Y. Matsuzawa.  Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.

[48]  J. Amado,et al.  Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. , 2005, The Journal of clinical endocrinology and metabolism.

[49]  G. Tenderich,et al.  Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? , 2003, Journal of the American College of Cardiology.